Dharmesh Shah recommended to keep stoploss at Rs 6650.
Investing.com – France stocks were lower after the close on Monday, as losses in the Foods & Drugs, Gas & Water and General Financial sectors led shares lower. At the close in...
Investing.com – France stocks were higher after the close on Friday, as gains in the Foods & Drugs, Gas & Water and General Financial sectors led shares higher. At the close in...
Third-quarter earnings performance of the big drugmakers has mostly been better than expected. J&J (NYSE:JNJ) , Bristol-Myers Merck, Novartis, Pfizer (NYSE:PFE) ,...
Inovio Pharmaceuticals, Inc.’s (NASDAQ:INO) adjusted loss of 27 cents per share in third-quarter 2019 was in line with the Zacks Consensus Estimate.Adjusted loss in the...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Sell||Neutral||Buy||Buy|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Buy||Strong Buy|
|Summary||Strong Sell||Strong Sell||Sell||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish doji Star||30||2||Nov 19, 2019 09:30AM|
|Engulfing Bearish||1W||3||Oct 27, 2019|
|Falling Three Methods||1W||3||Oct 27, 2019|
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.